drugset / Trial / NCT00136955
Irinotecan Study For Cervical Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the efficacy and safety of Irinotecan plus cisplatin as first-line chemotherapy for advanced or recurrent cervical cancer
Timeline
- Start
- 2004-06
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 60 mg/m2 | — |